News + Filings Holdings
All
13F
13D/G
Other
|
|
Soleus Capital Master Fund, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/16/2023 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 5.3% stake in Delcath Systems, Inc. |
| 08/11/2023 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 8.2% stake in Axogen, Inc. |
| 07/27/2023 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 5.1% stake in Verastem, Inc. |
| 04/14/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/22/2023 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 5.3% stake in RIGEL PHARMACEUTICALS INC. |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| Soleus Capital Master Fund, L.P. reports a 14% stake in EDAP TMS S.A. |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| Soleus Capital Master Fund, L.P. reports a 0% stake in APOLLO ENDOSURGERY, INC. |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| Soleus Capital Master Fund, L.P. reports a 9.9% stake in CELCUITY INC. |
| 01/30/2023 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 5.7% stake in JASPER THERAPEUTICS, INC. |
| 01/27/2023 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 5.4% stake in PIERIS PHARMACEUTICALS, INC. |
| 01/26/2023 |
SC 13G/A
| Soleus Capital Master Fund, L.P. reports a 1.3% stake in PIERIS PHARMACEUTICALS, INC. |
| 11/14/2022 |
SC 13G/A
| Soleus Capital Master Fund, L.P. reports a 10% stake in THERATECHNOLOGIES, INC. |
| 10/13/2022 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 5.1% stake in Organogenesis Holdings Inc. |
| 09/28/2022 |
SC 13G/A
| Soleus Capital Master Fund, L.P. reports a 13.4% stake in EDAP TMS S.A. |
| 09/02/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 09/02/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 09/01/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/18/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/10/2022 |
SC 13G/A
| Soleus Capital Master Fund, L.P. reports a 9.4% stake in EDAP TMS S.A. |
| 02/10/2022 |
SC 13G/A
| Soleus Capital Master Fund, L.P. reports a 9.6% stake in THERATECHNOLOGIES, INC. |
| 02/10/2022 |
SC 13G/A
| Soleus Capital Master Fund, L.P. reports a 5.8% stake in APOLLO ENDOSURGERY, INC. |
| 01/27/2022 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 5.4% stake in PIERIS PHARMACEUTICALS, INC. |
| 12/20/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/23/2021 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 7.8% stake in THERATECHNOLOGIES, INC. |
| 05/15/2020 |
4
| Soleus Private Equity GP I, LLC (10% Owner) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Converted 338,330 shares
@ $0
Converted 104,608 shares
@ $0
Sold 16,909 shares
@ $16, valued at
$270.5k
Bought 155,000 shares
@ $16, valued at
$2.5M
Converted 11,666,666 convertible preferred
@ $0
Converted 3,607,224 convertible preferred
@ $0
Exercised (in-or-at-the-money) 31,382 warrants
@ $8.63, valued at
$270.8k
|
|
|
|